BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9685662)

  • 1. Cannabinoid receptor CB1 mRNA is highly expressed in the rat ciliary body: implications for the antiglaucoma properties of marihuana.
    Porcella A; Casellas P; Gessa GL; Pani L
    Brain Res Mol Brain Res; 1998 Jul; 58(1-2):240-5. PubMed ID: 9685662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The human eye expresses high levels of CB1 cannabinoid receptor mRNA and protein.
    Porcella A; Maxia C; Gessa GL; Pani L
    Eur J Neurosci; 2000 Mar; 12(3):1123-7. PubMed ID: 10762343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of CB2 cannabinoid receptor mRNA in adult rat retina.
    Lu Q; Straiker A; Lu Q; Maguire G
    Vis Neurosci; 2000; 17(1):91-5. PubMed ID: 10750830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system.
    Schatz AR; Lee M; Condie RB; Pulaski JT; Kaminski NE
    Toxicol Appl Pharmacol; 1997 Feb; 142(2):278-87. PubMed ID: 9070350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization of cannabinoid CB1 receptors in the human anterior eye and retina.
    Straiker AJ; Maguire G; Mackie K; Lindsey J
    Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2442-8. PubMed ID: 10476817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoid CB(1) receptor expression, activation and detection of endogenous ligand in trabecular meshwork and ciliary process tissues.
    Stamer WD; Golightly SF; Hosohata Y; Ryan EP; Porter AC; Varga E; Noecker RJ; Felder CC; Yamamura HI
    Eur J Pharmacol; 2001 Nov; 431(3):277-86. PubMed ID: 11730719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations.
    Galiègue S; Mary S; Marchand J; Dussossoy D; Carrière D; Carayon P; Bouaboula M; Shire D; Le Fur G; Casellas P
    Eur J Biochem; 1995 Aug; 232(1):54-61. PubMed ID: 7556170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the CB1 and CB2 receptor messenger RNAs during embryonic development in the rat.
    Buckley NE; Hansson S; Harta G; Mezey E
    Neuroscience; 1998 Feb; 82(4):1131-49. PubMed ID: 9466436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabis and cannabinoids: pharmacology and rationale for clinical use.
    Pertwee RG
    Forsch Komplementarmed; 1999 Oct; 6 Suppl 3():12-5. PubMed ID: 10575283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the enzymatic stability and intraocular pressure effects of 2-arachidonylglycerol and noladin ether, a novel putative endocannabinoid.
    Laine K; Järvinen K; Mechoulam R; Breuer A; Järvinen T
    Invest Ophthalmol Vis Sci; 2002 Oct; 43(10):3216-22. PubMed ID: 12356827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cannabinoids on neural transmission in rat gastric fundus.
    Storr M; Gaffal E; Saur D; Schusdziarra V; Allescher HD
    Can J Physiol Pharmacol; 2002 Jan; 80(1):67-76. PubMed ID: 11911227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of CB1 mRNA upon activation of murine splenocytes.
    Noe SN; Newton C; Widen R; Friedman H; Klein TW
    Adv Exp Med Biol; 2001; 493():215-21. PubMed ID: 11727768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential roles of CB1 and CB2 cannabinoid receptors in mast cells.
    Samson MT; Small-Howard A; Shimoda LM; Koblan-Huberson M; Stokes AJ; Turner H
    J Immunol; 2003 May; 170(10):4953-62. PubMed ID: 12734338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of the CB2 cannabinoid receptor by rodent macrophages and macrophage-like cells in relation to cell activation.
    Carlisle SJ; Marciano-Cabral F; Staab A; Ludwick C; Cabral GA
    Int Immunopharmacol; 2002 Jan; 2(1):69-82. PubMed ID: 11789671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatostatin receptor gene expression in human ocular tissues: RT-PCR and immunohistochemical study.
    Klisovic DD; O'Dorisio MS; Katz SE; Sall JW; Balster D; O'Dorisio TM; Craig E; Lubow M
    Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2193-201. PubMed ID: 11527930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensinogen mRNA is synthesized locally in rat ocular tissues.
    Murata M; Nakagawa M; Takahashi S
    Ophthalmologica; 1997; 211(5):301-4. PubMed ID: 9286806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neuronal distribution of cannabinoid receptor type 1 in the trigeminal ganglion of the rat.
    Price TJ; Helesic G; Parghi D; Hargreaves KM; Flores CM
    Neuroscience; 2003; 120(1):155-62. PubMed ID: 12849749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of long-term exposure to delta9-THC on expression of cannabinoid receptor (CB1) mRNA in different rat brain regions.
    Zhuang S; Kittler J; Grigorenko EV; Kirby MT; Sim LJ; Hampson RE; Childers SR; Deadwyler SA
    Brain Res Mol Brain Res; 1998 Nov; 62(2):141-9. PubMed ID: 9813289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization of platelet-activating factor receptor messenger RNA in the rat eye.
    Mori M; Aihara M; Shimizu T
    Invest Ophthalmol Vis Sci; 1997 Nov; 38(12):2672-8. PubMed ID: 9375587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The synthetic cannabinoid WIN55212-2 decreases the intraocular pressure in human glaucoma resistant to conventional therapies.
    Porcella A; Maxia C; Gessa GL; Pani L
    Eur J Neurosci; 2001 Jan; 13(2):409-12. PubMed ID: 11168547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.